Title : Varenicline does not increase serum BDNF levels in patients with nicotine dependence.

Pub. Date : 2010 Apr

PMID : 20373480






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Varenicline, alpha4beta2 nicotinic acetylcholine receptor (nAChR) partial agonist, is a new class of medications for treating nicotine dependence. Varenicline cholinergic receptor nicotinic alpha 4 subunit Homo sapiens
2 As an alpha4beta2 nAChR partial agonist, varenicline serves to reduce nicotine withdrawal symptoms, while high-affinity binding of the agonist mitigates the reinforcing effects of smoking. Varenicline cholinergic receptor nicotinic alpha 4 subunit Homo sapiens